<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37051253</PMID><DateCompleted><Year>2023</Year><Month>04</Month><Day>14</Day></DateCompleted><DateRevised><Year>2023</Year><Month>04</Month><Day>15</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1664-3224</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>Frontiers in immunology</Title><ISOAbbreviation>Front Immunol</ISOAbbreviation></Journal><ArticleTitle>The genomic landscape of ANCA-associated vasculitis: Distinct transcriptional signatures, molecular endotypes and comparison with systemic lupus erythematosus.</ArticleTitle><Pagination><StartPage>1072598</StartPage><MedlinePgn>1072598</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1072598</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fimmu.2023.1072598</ELocationID><Abstract><AbstractText Label="INTRODUCTION">Anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitides (AAVs) present with a complex phenotype and are associated with high mortality and multi-organ involvement. We sought to define the transcriptional landscape and molecular endotypes of AAVs and compare it to systemic lupus erythematosus (SLE).</AbstractText><AbstractText Label="METHODS">We performed whole blood mRNA sequencing from 30 patients with AAV (granulomatosis with polyangiitis/GPA and microscopic polyangiitis/MPA) combined with functional enrichment and network analysis for aberrant pathways. Key genes and pathways were validated in an independent cohort of 18 AAV patients. Co-expression network and hierarchical clustering analysis, identified molecular endotypes. Multi-level transcriptional overlap analysis to SLE was based on our published data from 142 patients.</AbstractText><AbstractText Label="RESULTS">We report here that "Pan-vasculitis" signature contained 1,982 differentially expressed genes, enriched in leukocyte differentiation, cytokine signaling, type I and type II IFN signaling and aberrant B-T cell immunity. Active disease was characterized by signatures linked to cell cycle checkpoints and metabolism pathways, whereas ANCA-positive patients exhibited a humoral immunity transcriptional fingerprint. Differential expression analysis of GPA and MPA yielded an IFN-g pathway (in addition to a type I IFN) in the former and aberrant expression of genes related to autophagy and mRNA splicing in the latter. Unsupervised molecular taxonomy analysis revealed four endotypes with neutrophil degranulation, aberrant metabolism and B-cell responses as potential mechanistic drivers. Transcriptional perturbations and molecular heterogeneity were more pronounced in SLE. Molecular analysis and data-driven clustering of AAV uncovered distinct transcriptional pathways that could be exploited for targeted therapy.</AbstractText><AbstractText Label="DISCUSSION">We conclude that transcriptomic analysis of AAV reveals distinct endotypes and molecular pathways that could be targeted for therapy. The AAV transcriptome is more homogenous and less fragmented compared to the SLE which may account for its superior rates of response to therapy.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 Banos, Thomas, Garantziotis, Filia, Malissovas, Pieta, Nikolakis, Panagiotopoulos, Chalkia, Petras, Bertsias, Boumpas and Vassilopoulos.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Banos</LastName><ForeName>Aggelos</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Laboratory of Autoimmunity and Inflammation, Center for Clinical, Experimental Surgery and Translational Research, Biomedical Research Foundation of the Academy of Athens, Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thomas</LastName><ForeName>Konstantinos</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Clinical Immunology- Rheumatology Unit, 2nd Department of Medicine and Laboratory, General Hospital of Athens Ippokrateio, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garantziotis</LastName><ForeName>Panagiotis</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Laboratory of Autoimmunity and Inflammation, Center for Clinical, Experimental Surgery and Translational Research, Biomedical Research Foundation of the Academy of Athens, Athens, Greece.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department Rheumatology and Immunology, Hannover Medical School, Hannover, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Filia</LastName><ForeName>Anastasia</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Laboratory of Autoimmunity and Inflammation, Center for Clinical, Experimental Surgery and Translational Research, Biomedical Research Foundation of the Academy of Athens, Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Malissovas</LastName><ForeName>Nikolaos</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Laboratory of Autoimmunity and Inflammation, Center for Clinical, Experimental Surgery and Translational Research, Biomedical Research Foundation of the Academy of Athens, Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pieta</LastName><ForeName>Antigone</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Laboratory of Autoimmunity and Inflammation, Center for Clinical, Experimental Surgery and Translational Research, Biomedical Research Foundation of the Academy of Athens, Athens, Greece.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Rheumatology and Clinical Immunology Unit, 4th Department of Internal Medicine, Attikon University Hospital, Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nikolakis</LastName><ForeName>Dimitrios</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Laboratory of Autoimmunity and Inflammation, Center for Clinical, Experimental Surgery and Translational Research, Biomedical Research Foundation of the Academy of Athens, Athens, Greece.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Amsterdam Institute for Gastroenterology Endocrinology and Metabolism, Department of Gastroenterology, Academic Medical Center, Amsterdam University Medical Centers (UMC), University of Amsterdam, Amsterdam, Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Rheumatology and Clinical Immunology, Amsterdam Rheumatology &amp; Immunology Center (ARC), Amsterdam University Medical Centers (UMC), University of Amsterdam, Amsterdam, Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Amsterdam Institute for Infection &amp; Immunity, Department of Experimental Immunology, Amsterdam University Medical Centers (UMC), University of Amsterdam, Amsterdam, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Panagiotopoulos</LastName><ForeName>Alexandros G</ForeName><Initials>AG</Initials><AffiliationInfo><Affiliation>Clinical Immunology- Rheumatology Unit, 2nd Department of Medicine and Laboratory, General Hospital of Athens Ippokrateio, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chalkia</LastName><ForeName>Aglaia</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Nephrology Department, General Hospital of Athens Ippokrateio, Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Petras</LastName><ForeName>Dimitrios</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Nephrology Department, General Hospital of Athens Ippokrateio, Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bertsias</LastName><ForeName>George</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Rheumatology and Clinical Immunology, University Hospital of Heraklion, Medical School, University of Crete, Heraklion, Greece.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Immunity, Institute of Molecular Biology and Biotechnology-Foundation of Research and Technology-Hellas (FORTH), Heraklion, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boumpas</LastName><ForeName>Dimitrios T</ForeName><Initials>DT</Initials><AffiliationInfo><Affiliation>Laboratory of Autoimmunity and Inflammation, Center for Clinical, Experimental Surgery and Translational Research, Biomedical Research Foundation of the Academy of Athens, Athens, Greece.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Rheumatology and Clinical Immunology Unit, 4th Department of Internal Medicine, Attikon University Hospital, Athens, Greece.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Joint Academic Rheumatology Program, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vassilopoulos</LastName><ForeName>Dimitrios</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Clinical Immunology- Rheumatology Unit, 2nd Department of Medicine and Laboratory, General Hospital of Athens Ippokrateio, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Joint Academic Rheumatology Program, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>03</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Immunol</MedlineTA><NlmUniqueID>101560960</NlmUniqueID><ISSNLinking>1664-3224</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D019268">Antibodies, Antineutrophil Cytoplasmic</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D012333">RNA, Messenger</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019268" MajorTopicYN="N">Antibodies, Antineutrophil Cytoplasmic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D056648" MajorTopicYN="Y">Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="Y">Lupus Erythematosus, Systemic</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D023281" MajorTopicYN="N">Genomics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012333" MajorTopicYN="N">RNA, Messenger</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">autoimmune diseases</Keyword><Keyword MajorTopicYN="N">endotypes of disease</Keyword><Keyword MajorTopicYN="N">lupus (SLE)</Keyword><Keyword MajorTopicYN="N">transcriptomics (RNA-seq)</Keyword><Keyword MajorTopicYN="N">vasculitis</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>10</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>3</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>4</Month><Day>14</Day><Hour>6</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>4</Month><Day>13</Day><Hour>1</Hour><Minute>59</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>4</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37051253</ArticleId><ArticleId IdType="pmc">PMC10083368</ArticleId><ArticleId IdType="doi">10.3389/fimmu.2023.1072598</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Flossmann O, Berden A, de Groot K, Hagen C, Harper L, Heijl C, et al. . Long-term patient survival in ANCA-associated vasculitis. Ann Rheum Dis (2011) 70:488&#x2013;94. doi: 10.1136/ard.2010.137778</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/ard.2010.137778</ArticleId><ArticleId IdType="pubmed">21109517</ArticleId></ArticleIdList></Reference><Reference><Citation>Robson J, Doll H, Suppiah R, Flossmann O, Harper L, H&#xf6;glund P, et al. . Damage in the anca-associated vasculitides: Long-term data from the European vasculitis study group (EUVAS) therapeutic trials. Ann Rheum Dis (2015) 74:177&#x2013;84. doi: 10.1136/annrheumdis-2013-203927</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2013-203927</ArticleId><ArticleId IdType="pubmed">24243925</ArticleId></ArticleIdList></Reference><Reference><Citation>Jennette JC, Nachman PH. ANCA glomerulonephritis and vasculitis. Clin J Am Soc Nephrol (2017) 12:1680&#x2013;91. doi: 10.2215/CJN.02500317</Citation><ArticleIdList><ArticleId IdType="doi">10.2215/CJN.02500317</ArticleId><ArticleId IdType="pmc">PMC5628710</ArticleId><ArticleId IdType="pubmed">28842398</ArticleId></ArticleIdList></Reference><Reference><Citation>Walsh M, Flossmann O, Berden A, Westman K, H&#xf6;glund P, Stegeman C, et al. . Risk factors for relapse of antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Rheum (2012) 64:542&#x2013;8. doi: 10.1002/art.33361</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.33361</ArticleId><ArticleId IdType="pubmed">21953279</ArticleId></ArticleIdList></Reference><Reference><Citation>Kemna MJ, Damoiseaux J, Austen J, Winkens B, Peters J, van Paassen P, et al. . ANCA as a predictor of relapse: Useful in patients with renal involvement but not in patients with nonrenal disease. J Am Soc Nephrol (2015) 26:537&#x2013;42. doi: 10.1681/ASN.2013111233</Citation><ArticleIdList><ArticleId IdType="doi">10.1681/ASN.2013111233</ArticleId><ArticleId IdType="pmc">PMC4341475</ArticleId><ArticleId IdType="pubmed">25324502</ArticleId></ArticleIdList></Reference><Reference><Citation>Fussner LA, Hummel AM, Schroeder DR, Silva F, Cartin-Ceba R, Snyder MR, et al. . Factors determining the clinical utility of serial measurements of antineutrophil cytoplasmic antibodies targeting proteinase 3. Arthritis Rheumatol (2016) 68:1700&#x2013;10. doi: 10.1002/art.39637</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.39637</ArticleId><ArticleId IdType="pmc">PMC7137903</ArticleId><ArticleId IdType="pubmed">26882078</ArticleId></ArticleIdList></Reference><Reference><Citation>Specks U, Merkel PA, Seo P, Spiera R, Langford CA, Hoffman GS, et al. . Efficacy of remission-induction regimens for ANCA-associated vasculitis. N Engl J Med (2013) 369:417&#x2013;27. doi: 10.1056/NEJMoa1213277</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1213277</ArticleId><ArticleId IdType="pmc">PMC5953195</ArticleId><ArticleId IdType="pubmed">23902481</ArticleId></ArticleIdList></Reference><Reference><Citation>Guillevin L, Pagnoux C, Karras A, Khouatra C, Auma&#xee;tre O, Cohen P, et al. . Rituximab versus azathioprine for maintenance in ANCA-associated vasculitis. N Engl J Med (2014) 371:1771&#x2013;80. doi: 10.1056/NEJMoa1404231</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1404231</ArticleId><ArticleId IdType="pubmed">25372085</ArticleId></ArticleIdList></Reference><Reference><Citation>Jayne DRW, Merkel PA, Schall TJ, Bekker P, ADVOCATE Study Group . Avacopan for the treatment of ANCA-associated vasculitis. N Engl J Med (2021) 384:599&#x2013;609. doi: 10.1056/NEJMoa2023386</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2023386</ArticleId><ArticleId IdType="pubmed">33596356</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakazawa D, Masuda S, Tomaru U, Ishizu A. Pathogenesis and therapeutic interventions for ANCA-associated vasculitis. Nat Rev Rheumatol (2019) 15:91&#x2013;101. doi: 10.1038/s41584-018-0145-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41584-018-0145-y</ArticleId><ArticleId IdType="pubmed">30542206</ArticleId></ArticleIdList></Reference><Reference><Citation>Lyons PA, Rayner TF, Trivedi S, Holle JU, Watts RA, Jayne DR, et al. . Genetically distinct subsets within ANCA-associated vasculitis. New Engl J Med (2012) 367:214&#x2013;23. doi: 10.1056/NEJMoa1108735</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1108735</ArticleId><ArticleId IdType="pmc">PMC3773907</ArticleId><ArticleId IdType="pubmed">22808956</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie G, Roshandel D, Sherva R, Monach PA, Lu EY, Kung T, et al. . Association of granulomatosis with polyangiitis (Wegener&#x2019;s) with HLA-DPB1*04 and SEMA6A gene variants: Evidence from genome-wide analysis. Arthritis Rheum (2013) 65:2457&#x2013;68. doi: 10.1002/art.38036</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.38036</ArticleId><ArticleId IdType="pmc">PMC4471994</ArticleId><ArticleId IdType="pubmed">23740775</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawasaki A, Hasebe N, Hidaka M, Hirano F, Sada KE, Kobayashi S, et al. . Protective role of HLA-DRB1*13:02 against microscopic polyangiitis and MPO-ANCA-Positive vasculitides in a Japanese population: A case-control study. PloS One (2016) 11:e0154393. doi: 10.1371/journal.pone.0154393</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0154393</ArticleId><ArticleId IdType="pmc">PMC4868057</ArticleId><ArticleId IdType="pubmed">27166610</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao Y, Yang J, Colby K, Hogan SL, Hu Y, Jennette CE, et al. . High basal activity of the PTPN22 gain-of-Function variant blunts leukocyte responsiveness negatively affecting IL-10 production in ANCA vasculitis. PloS One (2012) 7:e42783. doi: 10.1371/journal.pone.0042783</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0042783</ArticleId><ArticleId IdType="pmc">PMC3411839</ArticleId><ArticleId IdType="pubmed">22880107</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang J, Ge H, Poulton CJ, Hogan SL, Hu Y, Jones BE, et al. . Histone modification signature at myeloperoxidase and proteinase 3 in patients with anti-neutrophil cytoplasmic autoantibody-associated vasculitis. Clin Epigenet (2016) 8:85. doi: 10.1186/s13148-016-0251-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13148-016-0251-0</ArticleId><ArticleId IdType="pmc">PMC5057507</ArticleId><ArticleId IdType="pubmed">27752292</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones BE, Yang J, Muthigi A, Hogan SL, Hu Y, Starmer J, et al. . Gene-specific DNA methylation changes predict remission in patients with ANCA-associated vasculitis. J Am Soc Nephrol (2017) 28:1175&#x2013;87. doi: 10.1681/ASN.2016050548</Citation><ArticleIdList><ArticleId IdType="doi">10.1681/ASN.2016050548</ArticleId><ArticleId IdType="pmc">PMC5373455</ArticleId><ArticleId IdType="pubmed">27821628</ArticleId></ArticleIdList></Reference><Reference><Citation>Kambas K, Chrysanthopoulou A, Vassilopoulos D, Apostolidou E, Skendros P, Girod A, et al. . Tissue factor expression in neutrophil extracellular traps and neutrophil derived microparticles in antineutrophil cytoplasmic antibody associated vasculitis may promote thromboinflammation and the thrombophilic state associated with the disease. Ann Rheum Dis (2014) 73:1854&#x2013;63. doi: 10.1136/annrheumdis-2013-203430</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2013-203430</ArticleId><ArticleId IdType="pubmed">23873874</ArticleId></ArticleIdList></Reference><Reference><Citation>von Borstel A, Sanders JS, Rutgers A, Stegeman CA, Heeringa P, Abdulahad WH. Cellular immune regulation in the pathogenesis of ANCA-associated vasculitides. Autoimmun Rev (2018) 17:413&#x2013;21. doi: 10.1016/j.autrev.2017.12.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2017.12.002</ArticleId><ArticleId IdType="pubmed">29428808</ArticleId></ArticleIdList></Reference><Reference><Citation>Flint S, McKinney E, Lyons P, Smith KG. The contribution of transcriptomics to biomarker development in systemic vasculitis and SLE. Curr Pharm Des (2015) 21:2225&#x2013;35. doi: 10.2174/1381612821666150313130256</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1381612821666150313130256</ArticleId><ArticleId IdType="pubmed">25771200</ArticleId></ArticleIdList></Reference><Reference><Citation>Panousis NI, Bertsias GK, Ongen H, Gergianaki I, Tektonidou MG, Trachana M, et al. . Combined genetic and transcriptome analysis of patients with SLE: distinct, targetable signatures for susceptibility and severity. Ann Rheum Dis (2019) 78:1079&#x2013;89. doi: 10.1136/annrheumdis-2018-214379</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2018-214379</ArticleId><ArticleId IdType="pmc">PMC6691930</ArticleId><ArticleId IdType="pubmed">31167757</ArticleId></ArticleIdList></Reference><Reference><Citation>McKinney EF, Lee JC, Jayne DR, Lyons PA, Smith KG. T-Cell exhaustion, co-stimulation and clinical outcome in autoimmunity and infection. Nature (2015) 523:612&#x2013;6. doi: 10.1038/nature14468</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature14468</ArticleId><ArticleId IdType="pmc">PMC4623162</ArticleId><ArticleId IdType="pubmed">26123020</ArticleId></ArticleIdList></Reference><Reference><Citation>McKinney EF, Lyons PA, Carr EJ, Hollis JL, Jayne DR, Willcocks LC, et al. . A CD8+ T cell transcription signature predicts prognosis in autoimmune disease. Nat Med (2010) 16:586&#x2013;91. doi: 10.1038/nm.2130</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.2130</ArticleId><ArticleId IdType="pmc">PMC3504359</ArticleId><ArticleId IdType="pubmed">20400961</ArticleId></ArticleIdList></Reference><Reference><Citation>Grayson PC, Carmona-Rivera C, Xu L, Lim N, Gao Z, Asare AL, et al. . Neutrophil-related gene expression and low-density granulocytes associated with disease activity and response to treatment in antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Rheumatol (2015) 67:1922&#x2013;32. doi: 10.1002/art.39153</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.39153</ArticleId><ArticleId IdType="pmc">PMC4485551</ArticleId><ArticleId IdType="pubmed">25891759</ArticleId></ArticleIdList></Reference><Reference><Citation>Gill EE, Smith ML, Gibson KM, Morishita KA, Lee AHY, Falsafi R, et al. . Different disease endotypes in phenotypically similar vasculitides affecting small-to-Medium sized blood vessels. Front Immunol (2021) 12:638571. doi:&#xa0;10.3389/fimmu.2021.638571</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.638571</ArticleId><ArticleId IdType="pmc">PMC7937946</ArticleId><ArticleId IdType="pubmed">33692808</ArticleId></ArticleIdList></Reference><Reference><Citation>Jennette JC, Falk RJ, Bacon PA, Basu N, Cid MC, Ferrario F, et al. . 2012 Revised international chapel hill consensus conference nomenclature of vasculitides. Arthritis Rheum (2013) 65:1&#x2013;11. doi: 10.1002/art.37715</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.37715</ArticleId><ArticleId IdType="pubmed">23045170</ArticleId></ArticleIdList></Reference><Reference><Citation>Ntatsaki E, Carruthers D, Chakravarty K, D'Cruz D, Harper L, Jayne D, et al. . BSR and BHPR guideline for the management of adults with ANCA-associated vasculitis. Rheumatology (2014) 53:2306&#x2013;9. doi: 10.1093/rheumatology/ket445</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/rheumatology/ket445</ArticleId><ArticleId IdType="pubmed">24729399</ArticleId></ArticleIdList></Reference><Reference><Citation>
Andrews S. FastQC a quality control tool for high throughput sequence data secondary . Available at: http://www.bioinformatics.babraham.ac.uk/projects/fastqc/.</Citation></Reference><Reference><Citation>Dobin A, Davis CA, Schlesinger F, Drenkow J, Zaleski C, Jha S, et al. . STAR: ultrafast universal RNA-seq aligner. Bioinformatics (2013) 29:15&#x2013;21. doi: 10.1093/bioinformatics/bts635</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/bts635</ArticleId><ArticleId IdType="pmc">PMC3530905</ArticleId><ArticleId IdType="pubmed">23104886</ArticleId></ArticleIdList></Reference><Reference><Citation>Anders S, Pyl PT, Huber W. HTSeq&#x2013;a Python framework to work with high-throughput sequencing data. Bioinformatics (2015) 31:166&#x2013;9. doi: 10.1093/bioinformatics/btu638</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btu638</ArticleId><ArticleId IdType="pmc">PMC4287950</ArticleId><ArticleId IdType="pubmed">25260700</ArticleId></ArticleIdList></Reference><Reference><Citation>Robinson MD, McCarthy DJ, Smyth GK. edgeR: a bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics (2010) 26:139&#x2013;40. doi: 10.1093/bioinformatics/btp616</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btp616</ArticleId><ArticleId IdType="pmc">PMC2796818</ArticleId><ArticleId IdType="pubmed">19910308</ArticleId></ArticleIdList></Reference><Reference><Citation>Reimand J, Kull M, Peterson H, Hansen J, Vilo J. g:Profiler&#x2013;a web-based toolset for functional profiling of gene lists from large-scale experiments. Nucleic Acids Res (2007) 35:W193&#x2013;200. doi: 10.1093/nar/gkm226</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkm226</ArticleId><ArticleId IdType="pmc">PMC1933153</ArticleId><ArticleId IdType="pubmed">17478515</ArticleId></ArticleIdList></Reference><Reference><Citation>Isserlin R, Merico D, Voisin V, Bader GD. Enrichment map &#x2013; a cytoscape app to visualize and explore OMICs pathway enrichment results. F1000Res (2014) 3:141. doi: 10.12688/f1000research.4536.1</Citation><ArticleIdList><ArticleId IdType="doi">10.12688/f1000research.4536.1</ArticleId><ArticleId IdType="pmc">PMC4103489</ArticleId><ArticleId IdType="pubmed">25075306</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu G, Wang L-G, Yan G-R, He QY. DOSE: an R/Bioconductor package for disease ontology semantic and enrichment analysis. Bioinformatics (2015) 31:608&#x2013;9. doi: 10.1093/bioinformatics/btu684</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btu684</ArticleId><ArticleId IdType="pubmed">25677125</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu G, He Q-Y. ReactomePA: an R/Bioconductor package for reactome pathway analysis and visualization. Mol Biosyst (2016) 12:477&#x2013;9. doi: 10.1039/C5MB00663E</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/C5MB00663E</ArticleId><ArticleId IdType="pubmed">26661513</ArticleId></ArticleIdList></Reference><Reference><Citation>Warde-Farley D, Donaldson SL, Comes O, Zuberi K, Badrawi R, Chao P, et al. . The GeneMANIA prediction server: Biological network integration for gene prioritization and predicting gene function. Nucleic Acids Res (2010) 38:W214&#x2013;20. doi: 10.1093/nar/gkq537</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkq537</ArticleId><ArticleId IdType="pmc">PMC2896186</ArticleId><ArticleId IdType="pubmed">20576703</ArticleId></ArticleIdList></Reference><Reference><Citation>Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, et al. . Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci (2005) 102:15545&#x2013;50. doi: 10.1073/pnas.0506580102</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0506580102</ArticleId><ArticleId IdType="pmc">PMC1239896</ArticleId><ArticleId IdType="pubmed">16199517</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen EY, Xu H, Gordonov S, Lim MP, Perkins MH, Ma'ayan A. Expression2Kinases: mRNA profiling linked to multiple upstream regulatory layers. Bioinformatics (2012) 28:105&#x2013;11. doi: 10.1093/bioinformatics/btr625</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btr625</ArticleId><ArticleId IdType="pmc">PMC3244772</ArticleId><ArticleId IdType="pubmed">22080467</ArticleId></ArticleIdList></Reference><Reference><Citation>Lachmann A, Ma&#x2019;ayan A. KEA: Kinase enrichment analysis. Bioinformatics (2009) 25:684&#x2013;6. doi: 10.1093/bioinformatics/btp026</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btp026</ArticleId><ArticleId IdType="pmc">PMC2647829</ArticleId><ArticleId IdType="pubmed">19176546</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu G, Wang L-G, Han Y, He QY. clusterProfiler: An r package for comparing biological themes among gene clusters. OMICS (2012) 16:284&#x2013;7. doi: 10.1089/omi.2011.0118</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/omi.2011.0118</ArticleId><ArticleId IdType="pmc">PMC3339379</ArticleId><ArticleId IdType="pubmed">22455463</ArticleId></ArticleIdList></Reference><Reference><Citation>Devaiah BN, Lu H, Gegonne A, Sercan Z, Zhang H, Clifford RJ, et al. . Novel functions for TAF7, a regulator of TAF1-independent transcription. J Biol Chem (2010) 285:38772&#x2013;80. doi: 10.1074/jbc.M110.173864</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M110.173864</ArticleId><ArticleId IdType="pmc">PMC2998114</ArticleId><ArticleId IdType="pubmed">20937824</ArticleId></ArticleIdList></Reference><Reference><Citation>Gordon S, Akopyan G, Garban H, Bonavida B. Transcription factor YY1: structure, function, and therapeutic implications in cancer biology. Oncogene (2006) 25:1125&#x2013;42. doi: 10.1038/sj.onc.1209080</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.onc.1209080</ArticleId><ArticleId IdType="pubmed">16314846</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsai M-H, Pai L-M, Lee C-K. Fine-tuning of type I interferon response by STAT3. Front Immunol (2019) 10:1448. doi:&#xa0;10.3389/fimmu.2019.01448</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2019.01448</ArticleId><ArticleId IdType="pmc">PMC6606715</ArticleId><ArticleId IdType="pubmed">31293595</ArticleId></ArticleIdList></Reference><Reference><Citation>Moiseeva TN, Bottrill A, Melino G, Barlev NA. DNA Damage-induced ubiquitylation of proteasome controls its proteolytic activity. Oncotarget (2013) 4:1338&#x2013;48. doi: 10.18632/oncotarget.1060</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/oncotarget.1060</ArticleId><ArticleId IdType="pmc">PMC3824523</ArticleId><ArticleId IdType="pubmed">23907514</ArticleId></ArticleIdList></Reference><Reference><Citation>Clarke DJB, Kuleshov MV, Schilder BM, Torre D, Duffy ME, Keenan AB, et al. . eXpression2Kinases (X2K) web: linking expression signatures to upstream cell signaling networks. Nucleic Acids Res (2018) 46:W171&#x2013;9. doi: 10.1093/nar/gky458</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gky458</ArticleId><ArticleId IdType="pmc">PMC6030863</ArticleId><ArticleId IdType="pubmed">29800326</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y, Luo H, Liu T, Zacksenhaus E, Ben-David Y. The ets transcription factor fli-1 in development, cancer and disease. Oncogene (2015) 34:2022&#x2013;31. doi: 10.1038/onc.2014.162</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/onc.2014.162</ArticleId><ArticleId IdType="pmc">PMC5028196</ArticleId><ArticleId IdType="pubmed">24909161</ArticleId></ArticleIdList></Reference><Reference><Citation>Wen AY, Sakamoto KM, Miller LS. The role of the transcription factor CREB in immune function. J Immunol (2010) 185:6413&#x2013;9. doi: 10.4049/jimmunol.1001829</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1001829</ArticleId><ArticleId IdType="pmc">PMC5519339</ArticleId><ArticleId IdType="pubmed">21084670</ArticleId></ArticleIdList></Reference><Reference><Citation>McMahon SB, van Buskirk HA, Dugan KA, Copeland TD, Cole MD. The novel ATM-related protein TRRAP is an essential cofactor for the c-myc and E2F oncoproteins. Cell (1998) 94:363&#x2013;74. doi: 10.1016/S0092-8674(00)81479-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0092-8674(00)81479-8</ArticleId><ArticleId IdType="pubmed">9708738</ArticleId></ArticleIdList></Reference><Reference><Citation>Tapias A, Zhou Z-W, Shi Y, Chong Z, Wang P, Groth M, et al. . Trrap-dependent histone acetylation specifically regulates cell-cycle gene transcription to control neural progenitor fate decisions. Cell Stem Cell (2014) 14:632&#x2013;43. doi: 10.1016/j.stem.2014.04.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stem.2014.04.001</ArticleId><ArticleId IdType="pubmed">24792116</ArticleId></ArticleIdList></Reference><Reference><Citation>Falk RJ, Terrell RS, Charles LA, Jennette JC. Anti-neutrophil cytoplasmic autoantibodies induce neutrophils to degranulate and produce oxygen radicals in vitro . Proc Natl Acad Sci (1990) 87:4115&#x2013;9. doi: 10.1073/pnas.87.11.4115</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.87.11.4115</ArticleId><ArticleId IdType="pmc">PMC54058</ArticleId><ArticleId IdType="pubmed">2161532</ArticleId></ArticleIdList></Reference><Reference><Citation>Charles LA, Caldas MLR, Falk RJ, Terrell RS, Jennette JC. Antibodies against granule proteins activate neutrophils. In Vitro J Leukoc Biol (1991) 50:539&#x2013;46. doi: 10.1002/jlb.50.6.539</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jlb.50.6.539</ArticleId><ArticleId IdType="pubmed">1658170</ArticleId></ArticleIdList></Reference><Reference><Citation>Kessenbrock K, Krumbholz M, Sch&#xf6;nermarck U, Back W, Gross WL, Werb Z, et al. . Netting neutrophils in autoimmune small-vessel vasculitis. Nat Med (2009) 15:623&#x2013;5. doi: 10.1038/nm.1959</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.1959</ArticleId><ArticleId IdType="pmc">PMC2760083</ArticleId><ArticleId IdType="pubmed">19448636</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakazawa D, Shida H, Kusunoki Y, Miyoshi A, Nishio S, Tomaru U, et al. . The responses of macrophages in interaction with neutrophils that undergo NETosis. J Autoimmun (2016) 67:19&#x2013;28. doi: 10.1016/j.jaut.2015.08.018</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaut.2015.08.018</ArticleId><ArticleId IdType="pubmed">26347075</ArticleId></ArticleIdList></Reference><Reference><Citation>Carmona-Rivera C, Kaplan MJ. Low-density granulocytes: a distinct class of neutrophils in systemic autoimmunity. Semin Immunopathol (2013) 35:455&#x2013;63. doi: 10.1007/s00281-013-0375-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00281-013-0375-7</ArticleId><ArticleId IdType="pmc">PMC4007274</ArticleId><ArticleId IdType="pubmed">23553215</ArticleId></ArticleIdList></Reference><Reference><Citation>Csernok E, Ai M, Gross WL, Wicklein D, Petersen A, Lindner B, et al. . Wegener autoantigen induces maturation of dendritic cells and licenses them for Th1 priming via the protease-activated receptor-2 pathway. Blood (2006) 107:4440&#x2013;8. doi: 10.1182/blood-2005-05-1875</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2005-05-1875</ArticleId><ArticleId IdType="pubmed">16478888</ArticleId></ArticleIdList></Reference><Reference><Citation>Rice CM, Davies LC, Subleski JJ, Maio N, Gonzalez-Cotto M, Andrews C, et al. . Tumour-elicited neutrophils engage mitochondrial metabolism to circumvent nutrient limitations and maintain immune suppression. Nat Commun (2018) 9:5099. doi: 10.1038/s41467-018-07505-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-018-07505-2</ArticleId><ArticleId IdType="pmc">PMC6269473</ArticleId><ArticleId IdType="pubmed">30504842</ArticleId></ArticleIdList></Reference><Reference><Citation>Kraaij T, Kamerling SWA, van Dam LS, Bakker JA, Bajema IM, Page T, et al. . Excessive neutrophil extracellular trap formation in ANCA-associated vasculitis is independent of ANCA. Kidney Int (2018) 94:139&#x2013;49. doi: 10.1016/j.kint.2018.01.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.kint.2018.01.013</ArticleId><ArticleId IdType="pubmed">29606398</ArticleId></ArticleIdList></Reference><Reference><Citation>Souliotis VL, Sfikakis PP. Increased DNA double-strand breaks and enhanced apoptosis in patients with lupus nephritis. Lupus (2015) 24:804&#x2013;15. doi: 10.1177/0961203314565413</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203314565413</ArticleId><ArticleId IdType="pubmed">25542905</ArticleId></ArticleIdList></Reference><Reference><Citation>Souliotis VL, Vlachogiannis NI, Pappa M, Argyriou A, Sfikakis PP. DNA Damage accumulation, defective chromatin organization and deficient DNA repair capacity in patients with rheumatoid arthritis. Clin Immunol (2019) 203:28&#x2013;36. doi: 10.1016/j.clim.2019.03.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clim.2019.03.009</ArticleId><ArticleId IdType="pubmed">30930144</ArticleId></ArticleIdList></Reference><Reference><Citation>Shao W-H, Cohen PL. Disturbances of apoptotic cell clearance in systemic lupus erythematosus. Arthritis Res Ther (2010) 13:202. doi: 10.1186/ar3206</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/ar3206</ArticleId><ArticleId IdType="pmc">PMC3157636</ArticleId><ArticleId IdType="pubmed">21371352</ArticleId></ArticleIdList></Reference><Reference><Citation>Palomino GM, Bassi CL, Wastowski IJ, Xavier DJ, Lucisano-Valim YM, Crispim JC, et al. . Patients with systemic sclerosis present increased DNA damage differentially associated with DNA repair gene polymorphisms. J Rheumatol (2014) 41:458&#x2013;65. doi: 10.3899/jrheum.130376</Citation><ArticleIdList><ArticleId IdType="doi">10.3899/jrheum.130376</ArticleId><ArticleId IdType="pubmed">24488411</ArticleId></ArticleIdList></Reference><Reference><Citation>Bokhari B, Sharma S. Stress marks on the genome: Use or lose? Int J Mol Sci (2019) 20:364. doi: 10.3390/ijms20020364</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms20020364</ArticleId><ArticleId IdType="pmc">PMC6358951</ArticleId><ArticleId IdType="pubmed">30654540</ArticleId></ArticleIdList></Reference><Reference><Citation>H&#xe4;rtlova A, Erttmann SF, Raffi FA, Schmalz AM, Resch U, Anugula S, et al. . DNA Damage primes the type I interferon system via the cytosolic DNA sensor STING to promote anti-microbial innate immunity. Immunity (2015) 42:332&#x2013;43. doi: 10.1016/j.immuni.2015.01.012</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2015.01.012</ArticleId><ArticleId IdType="pubmed">25692705</ArticleId></ArticleIdList></Reference><Reference><Citation>Garantziotis P, Nikolakis D, Doumas S, Frangou E, Sentis G, Filia A, et al. . Molecular taxonomy of systemic lupus erythematosus through data-driven patient stratification: Molecular endotypes and cluster-tailored drugs. Front Immunol (2022) 13:860726. doi:&#xa0;10.3389/fimmu.2022.860726</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.860726</ArticleId><ArticleId IdType="pmc">PMC9125979</ArticleId><ArticleId IdType="pubmed">35615355</ArticleId></ArticleIdList></Reference><Reference><Citation>Ntasis VF, Panousis NI, Tektonidou MG, Dermitzakis ET, Boumpas DT, Bertsias GK, et al. . Extensive fragmentation and re-organization of transcription in systemic lupus erythematosus. Sci Rep (2020) 10:16648. doi: 10.1038/s41598-020-73654-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-73654-4</ArticleId><ArticleId IdType="pmc">PMC7539002</ArticleId><ArticleId IdType="pubmed">33024230</ArticleId></ArticleIdList></Reference><Reference><Citation>Pu&#xe9;chal X, Iudici M, Pagnoux C, Cohen P, Hamidou M, Aouba A, et al. . Comparative study of granulomatosis with polyangiitis subsets according to ANCA status: data from the French vasculitis study group registry. RMD Open (2022) 8. doi:&#xa0;10.1136/rmdopen-2021-002160</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/rmdopen-2021-002160</ArticleId><ArticleId IdType="pmc">PMC8928389</ArticleId><ArticleId IdType="pubmed">35296533</ArticleId></ArticleIdList></Reference><Reference><Citation>Miloslavsky EM, Lu N, Unizony S, Choi HK, Merkel PA, Seo P, et al. . Myeloperoxidase-antineutrophil cytoplasmic antibody (ANCA)-positive and ANCA-negative patients with granulomatosis with polyangiitis (Wegener&#x2019;s): Distinct patient subsets. Arthritis Rheumatol (2016) 68:2945&#x2013;52. doi: 10.1002/art.39812</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.39812</ArticleId><ArticleId IdType="pmc">PMC5541999</ArticleId><ArticleId IdType="pubmed">27428559</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang D-Y, Li Z-Y, Chen M, Zhao MH. Myeloperoxidase-ANCA-positive granulomatosis with polyangiitis is a distinct subset of ANCA-associated vasculitis: A retrospective analysis of 455 patients from a single center in China. Semin Arthritis Rheum (2019) 48:701&#x2013;6. doi: 10.1016/j.semarthrit.2018.05.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.semarthrit.2018.05.003</ArticleId><ArticleId IdType="pubmed">29887327</ArticleId></ArticleIdList></Reference><Reference><Citation>Schirmer JH, Wright MN, Herrmann K, Laudien M, N&#xf6;lle B, Reinhold-Keller E, et al. . Myeloperoxidase-antineutrophil cytoplasmic antibody (ANCA)-positive granulomatosis with polyangiitis (Wegener&#x2019;s) is a clinically distinct subset of ANCA-associated vasculitis: A retrospective analysis of 315 patients from a German vasculitis referral center. Arthritis Rheumatol (2016) 68:2953&#x2013;63. doi: 10.1002/art.39786</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.39786</ArticleId><ArticleId IdType="pubmed">27333332</ArticleId></ArticleIdList></Reference><Reference><Citation>Perez RK, Gordon MG, Subramaniam M, Kim MC, Hartoularos GC, Targ S, et al. . Single-cell RNA-seq reveals cell type&#x2013;specific molecular and genetic associations to lupus. Sci (1979) (2022) 376. doi:&#xa0;10.1126/science.abf1970</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abf1970</ArticleId><ArticleId IdType="pmc">PMC9297655</ArticleId><ArticleId IdType="pubmed">35389781</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang F, Wei K, Slowikowski K, Fonseka CY, Rao DA, Kelly S, et al. . Defining inflammatory cell states in rheumatoid arthritis joint synovial tissues by integrating single-cell transcriptomics and mass cytometry. Nat Immunol (2019) 20:928&#x2013;42. doi: 10.1038/s41590-019-0378-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-019-0378-1</ArticleId><ArticleId IdType="pmc">PMC6602051</ArticleId><ArticleId IdType="pubmed">31061532</ArticleId></ArticleIdList></Reference><Reference><Citation>Qing G, Zhiyuan W, Jinge Y, Yuqing M, Zuoguan C, Yongpeng D, et al. . Single-cell RNA sequencing revealed CD14+ monocytes increased in patients with takayasu&#x2019;s arteritis requiring surgical management. Front Cell Dev Biol (2021) 9:761300. doi:&#xa0;10.3389/fcell.2021.761300</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcell.2021.761300</ArticleId><ArticleId IdType="pmc">PMC8521054</ArticleId><ArticleId IdType="pubmed">34671607</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng W, Wang X, Liu J, Yu X, Li L, Wang H, et al. . Single-cell analyses highlight the proinflammatory contribution of C1q-high monocytes to beh&#xe7;et&#x2019;s disease. Proc Natl Acad Sci (2022) 119. doi:&#xa0;10.1073/pnas.2204289119</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2204289119</ArticleId><ArticleId IdType="pmc">PMC9245671</ArticleId><ArticleId IdType="pubmed">35727985</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Z, Xie L, Ding G, Song S, Chen L, Li G, et al. . Single-cell RNA sequencing of peripheral blood mononuclear cells from acute Kawasaki disease patients. Nat Commun (2021) 12:5444. doi: 10.1038/s41467-021-25771-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-25771-5</ArticleId><ArticleId IdType="pmc">PMC8440575</ArticleId><ArticleId IdType="pubmed">34521850</ArticleId></ArticleIdList></Reference><Reference><Citation>Porritt RA, Zemmour D, Abe M, Lee Y, Narayanan M, Carvalho TT, et al. . NLRP3 inflammasome mediates immune-stromal interactions in vasculitis. Circ Res (2021) 129:e183&#x2013;e200. doi:&#xa0;10.1161/CIRCRESAHA.121.319153</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.121.319153</ArticleId><ArticleId IdType="pmc">PMC8555446</ArticleId><ArticleId IdType="pubmed">34517723</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>